These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24595055)

  • 1. Casein kinase II induced polymerization of soluble TDP-43 into filaments is inhibited by heat shock proteins.
    Carlomagno Y; Zhang Y; Davis M; Lin WL; Cook C; Dunmore J; Tay W; Menkosky K; Cao X; Petrucelli L; Deture M
    PLoS One; 2014; 9(3):e90452. PubMed ID: 24595055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation.
    Nagata E; Nonaka T; Moriya Y; Fujii N; Okada Y; Tsukamoto H; Itoh J; Okada C; Satoh T; Arai T; Hasegawa M; Takizawa S
    Mol Neurobiol; 2016 Oct; 53(8):5377-83. PubMed ID: 26440668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 43-kDa TDP-43 species is present in aggregates associated with frontotemporal lobar degeneration.
    Bosque PJ; Boyer PJ; Mishra P
    PLoS One; 2013; 8(5):e62301. PubMed ID: 23704877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 skeins show properties of amyloid in a subset of ALS cases.
    Robinson JL; Geser F; Stieber A; Umoh M; Kwong LK; Van Deerlin VM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2013 Jan; 125(1):121-31. PubMed ID: 23124365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases.
    Lin WL; Dickson DW
    Acta Neuropathol; 2008 Aug; 116(2):205-13. PubMed ID: 18607609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An
    Cascella R; Banchelli M; Abolghasem Ghadami S; Ami D; Gagliani MC; Bigi A; Staderini T; Tampellini D; Cortese K; Cecchi C; Natalello A; Adibi H; Matteini P; Chiti F
    Ann Med; 2023 Dec; 55(1):72-88. PubMed ID: 36495262
    [No Abstract]   [Full Text] [Related]  

  • 10. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Riku Y
    Neuropathology; 2020 Oct; 40(5):426-435. PubMed ID: 32157757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
    Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
    Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
    Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of pathological TDP-43 filaments from ALS with FTLD.
    Arseni D; Hasegawa M; Murzin AG; Kametani F; Arai M; Yoshida M; Ryskeldi-Falcon B
    Nature; 2022 Jan; 601(7891):139-143. PubMed ID: 34880495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
    Tsai KJ; Yang CH; Fang YH; Cho KH; Chien WL; Wang WT; Wu TW; Lin CP; Fu WM; Shen CK
    J Exp Med; 2010 Aug; 207(8):1661-73. PubMed ID: 20660618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis.
    Chen HJ; Mitchell JC; Novoselov S; Miller J; Nishimura AL; Scotter EL; Vance CA; Cheetham ME; Shaw CE
    Brain; 2016 May; 139(Pt 5):1417-32. PubMed ID: 26936937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Baloh RH
    FEBS J; 2011 Oct; 278(19):3539-49. PubMed ID: 21777387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.
    Zhang YJ; Xu YF; Cook C; Gendron TF; Roettges P; Link CD; Lin WL; Tong J; Castanedes-Casey M; Ash P; Gass J; Rangachari V; Buratti E; Baralle F; Golde TE; Dickson DW; Petrucelli L
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7607-12. PubMed ID: 19383787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.